These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7136941)

  • 1. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks.
    Roberts LJ; Turk JW; Oates JA
    Adv Shock Res; 1982; 8():145-52. PubMed ID: 7136941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production.
    Kootte AM; Haak A; Roberts LJ
    Neth J Med; 1983; 26(1):18-20. PubMed ID: 6572798
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition.
    Crawhall JC; Wilkinson RD
    Clin Invest Med; 1987 Jan; 10(1):1-4. PubMed ID: 2880686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention with epinephrine in hypotension associated with mastocytosis.
    Turk J; Oates JA; Roberts LJ
    J Allergy Clin Immunol; 1983 Feb; 71(2):189-92. PubMed ID: 6296213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of prostaglandin D2 in patients with systemic mastocytosis.
    Roberts LJ; Sweetman BJ; Lewis RA; Austen KF; Oates JA
    N Engl J Med; 1980 Dec; 303(24):1400-4. PubMed ID: 6107852
    [No Abstract]   [Full Text] [Related]  

  • 7. Markedly increased synthesis of prostaglandin D2 in systemic mastocytosis.
    Roberts LJ; Sweetman BJ; Lewis RA; Folarin VF; Austen KF; Oates JA
    Trans Assoc Am Physicians; 1980; 93():141-7. PubMed ID: 7245571
    [No Abstract]   [Full Text] [Related]  

  • 8. [A rare cause of loss of consciousness: mastocytosis. Apropos of 3 cases].
    Dacosta A; Guy JM; Cathebras P; Perrot JL; Decousus H; Tardy B; Gonthier R; Lamaud M; Rousset H; Verneyre H
    Arch Mal Coeur Vaiss; 1993 Dec; 86(12):1747-52. PubMed ID: 8024376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazards in operative management of patients with systemic mastocytosis.
    Scott HW; Parris WC; Sandidge PC; Oates JA; Roberts LJ
    Ann Surg; 1983 May; 197(5):507-14. PubMed ID: 6189461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shock and coagulation disorders in systemic mastocytosis].
    Hansen U; Wiese R; Knolle J
    Dtsch Med Wochenschr; 1994 Sep; 119(37):1231-4. PubMed ID: 7924907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis.
    Poynard T; Nataf C; Messing B; Modigliani R; Lecompte T; Nicolas P; Dray F; Ferme C
    N Engl J Med; 1982 Jul; 307(3):186. PubMed ID: 6953312
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review.
    Shaffer HC; Parsons DJ; Peden DB; Morrell D
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S210-3. PubMed ID: 16631942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis.
    Roberts LJ; Sweetman BJ
    Prostaglandins; 1985 Sep; 30(3):383-400. PubMed ID: 3864190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anesthetic management of a patient with urticaria pigmentosa].
    Koitabashi T; Takino Y
    Masui; 1995 Feb; 44(2):279-81. PubMed ID: 7739106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of aspirin administration in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):122-4. PubMed ID: 19429499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell mediators in allergic inflammation and mastocytosis.
    Castells M
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):465-85. PubMed ID: 16931289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope.
    Roberts LJ; Fields JP; Oates JA
    Trans Assoc Am Physicians; 1982; 95():36-41. PubMed ID: 7182985
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic mastocytosis: current concepts and treatment advances.
    Tefferi A; Pardanani A
    Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of mastocytosis: an overview.
    Metcalfe DD
    J Invest Dermatol; 1991 Mar; 96(3):55S-56S; discussion 56S-59S. PubMed ID: 2002266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic mastocytosis: clinical case].
    Mardones P; Moyano C; Peña K; Quijada C
    Rev Med Chil; 1998 Jul; 126(7):823-7. PubMed ID: 9830775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.